Skip to main content
Home > SciBX on Science > Therapeutics

Chronological Index of SciBX: The Science-Business eXchange: Therapeutics

SciBX: The Science-Business eXchange Current Issue
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Neutrophil elastase (NE; ELA-2); cyclin E (CCNE) In vitro studies …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Phosphoinositide 3-kinase-b (PI3Kb); PTEN (MMAC1; TEP1) A study in mice …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Pancreatic cancer Glutamine-fructose-6-phosphate transaminase 1 (GFPT1); K-Ras; …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Arrhythmia Phosphoinositide 3-kinase (PI3K) In vitro and mouse …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiomyopathy VEGF receptor 1 (FLT1; VEGFR-1) Human and mouse …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiovascular disease Perilipin 5 (PLIN5) Mouse studies suggest …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Heart failure Toll-like receptor 9 (TLR9) Mouse studies suggest …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes; dyslipidemia Not applicable Rodent studies suggest…

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Bacterial infection DNA repair In vitro studies identified a common …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Influenza virus Influenza A virus PB1-F2 protein (PB1-F2) In vitro …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation Phosphoinositide 3-kinase-g (PI3Kg) In vitro and mouse studies…

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Huntington's disease (HD) Diacylglycerol kinase-e (DGKE) Mouse, fly and cell …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Pain Bradykinin B1 receptor (BDKRB1; B1R) An in vitro and mouse study …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Pain Monoacylglycerol lipase (MAGL) In vitro and rodent studies identified a …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Ophthalmic disease Age-related macular degeneration (AMD) IL-18 Mouse studies suggest …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Ophthalmic disease Age-related macular degeneration (AMD) Myeloid differentiation primary…

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Emphysema Sirtuin 1 (SIRT1) Mouse studies suggest activating SIRT1 …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Nephropathy Uromodulin (UMOD; THP) Rat studies suggest antagonizing UMOD …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Autoimmune disease; inflammation Phosphoinositide 3-kinase-g (PI3Kg) In vitro, …

    Published on 5/17/2012
  • Therapeutics

    This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Cancer; sepsis Heat shock protein 90 (Hsp90); lipopolysaccharide (LPS) Cell …

    Published on 5/17/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune disease Dedicator of cytokinesis 2 (DOCK2) In vitro and mouse studies identified a …

    Published on 5/10/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Multiple sclerosis (MS) MicroRNA-301a (miR-301a) A study in mice suggests antagonizing miR-301a …

    Published on 5/10/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Hedgehog pathway; P glycoprotein (MDR1; ABCB1; P-gp; CD243) Mouse studies suggest P-gp …

    Published on 5/10/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Autophagy In vitro and mouse studies suggest dimeric chloroquine analogs could help treat cancer more…

    Published on 5/10/2012
  • Therapeutics

    Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Solid tumors Glucose-6-phosphate dehydrogenase (G6PD) An SAR study identified G6PD inhibitors that could be …

    Published on 5/10/2012

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993

Log In


Forgot password  |  Forgot Login


If you are a subscriber, but have forgotten or have never received a password, please go here and ask us to send you a new one.

SciBX: Science-Business eXchange

BioCentury's weekly translational science journal, published in collaboration with Nature Publishing Group:

  • Selects from hundreds of scientific papers published each week to identify early opportunities for investment, alliances and partnerships
  • Reports on the most commercially relevant developments